Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

14-555-M

Sigma-Aldrich

Alk Protein, active, 10 µg

Active, N-terminal His6-tagged, recombinant human ALK, residues 1058-end, for use in Kinase Assays.

Synonyme(s) :

Anaplastic lymphoma kinase

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
12352202
eCl@ss :
32160405
Nomenclature NACRES :
NA.32

Source biologique

human

Niveau de qualité

Produit recombinant

expressed in baculovirus infected Sf21 cells

Poids mol.

Mw 63.8 kDa

Fabricant/nom de marque

Upstate®

Technique(s)

activity assay: suitable (kinase)

Numéro d'accès NCBI

Numéro d'accès UniProt

Description générale

Research area: CELL SIGNALING

Product Source: expressed by baculovirus in Sf21 cells

The anaplastic lymphoma kinase (ALK) is a member of the insulin receptor superfamily of receptor tyrosine kinases. The ALK gene is located on human chromosome 2p23 and shares a high similarity with the leukocyte tyrosine kinase (Ltk). ALK is composed of three domains: an extracellular domain responsible for ligand binding, a transmembrane domain that spans the cell membrane, and a cytoplasmic domain housing the tyrosine kinase activity. The cytoplasmic tyrosine kinase domain of ALK plays a significant role in disease pathologies associated with the gene. Within the structure, there are two short conserved β-strands (β7-β8) housing majority of the catalytic residues. Full-length ALK is specifically expressed in the developing central and peripheral nervous systems during embryogenesis and is associated with the balance of cell proliferation and differentiation.

Application

Research Category

Inflammation & Immunology

Actions biochimiques/physiologiques

Protein Target: ALK

Target Sub-Family: TK Anaplastic lymphoma kinase (ALK) plays a crucial role in the development of neurons. Binding of ligand to its extracellular domain triggers the activation of the tyrosine kinase that in turn activates the mitogen-activated protein kinase (MAPK) pathway. ALK fusion proteins induce the activation of diverse pathways including Phospholipase C gamma (PLC-γ) and Ras/Extracellular Signal-Regulated Kinase 1/2 (Ras/ERK1/2), which contribute to cell proliferation, while the Janus Kinase/signal transducer and activator of transcription (JAK/STAT) pathway and Phosphoinositide 3-kinase/Protein Kinase B (PI3K/Akt) pathways facilitate cell survival. Notably, ALK has been found to be overexpressed in various human tumors and cell lines such as lymphomas, neuroblastoma, and non-small-cell lung cancer.

Qualité

routinely evaluated by phosphorylation of IGF-1Rtide

Forme physique

Ni2+/NTA-agarose

Stockage et stabilité

6 months at -70°C from date of shipment

Autres remarques

For Specific Activity data, refer to the Certificate of Analysis for individual lots of this enzyme.

Informations légales

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Hallberg B and Palmer RH
Nature Reviews. Cancer, 13(10), 685-700 (2013)
ALK a novel lymphoma-associated tumor antigen for vaccination strategies.
Passoni, Lorena and Gambacorti-Passerini, Carlo
Leukemia & Lymphoma, 44, 1675-1681 (2003)
Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition
Roskoski R Jr
Pharmacological Research, 68(1), 68-94 (2013)
Anaplastic lymphoma kinase proteins in growth control and cancer.
Pulford, K, et al.
Journal of Cellular Physiology, 199, 330-358 (2004)
Mechanism for the activation of the anaplastic lymphoma kinase receptor
Reshetnyak AV, et al.
Nature, 600(7887), 153-157 (2021)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique